Cargando…

Recurrent acute coronary syndrome after infliximab infusion in a patient with rheumatoid arthritis: Case report

CASE DESCRIPTION: A 61-year-old male patient with uncontrolled rheumatoid arthritis presented acute coronary syndrome on three occasions, less than 48 hours after infliximab infusion. CLINICAL FINDINGS: He presented with ST-elevation myocardial infarction on two occasions and non-ST-elevation acute...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rebolledo Del Toro, Martin, Borda, Camila, Rincón, Luisa Fernanda, Castillo, Andrea, Fernández-Ávila, Daniel Gerardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Universidad del Valle 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473013/ https://www.ncbi.nlm.nih.gov/pubmed/37664645 http://dx.doi.org/10.25100/cm.v54i2.5466

Ejemplares similares

Infliximab in the treatment of rheumatoid arthritis
por: Perdriger, A
Publicado: (2009)

Recurrent and refractory corneal perforation secondary to rheumatoid arthritis treated with infliximab
por: Al Saleh, Ahmed, et al.
Publicado: (2021)

Pneumococcal polyarticular septic arthritis after a single infusion of infliximab in a rheumatoid arthritis patient: a case report
por: Hayashi, Masatoshi, et al.
Publicado: (2012)

How does infliximab work in rheumatoid arthritis?
por: Maini, Ravinder N, et al.
Publicado: (2002)

Predictors of infusion reactions during infliximab treatment in patients with arthritis
por: Kapetanovic, Meliha C, et al.
Publicado: (2006)

Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis
por: Okuyama, Ayumi, et al.
Publicado: (2010)

Infliximab improves vascular stiffness in patients with rheumatoid arthritis
por: Wong, M, et al.
Publicado: (2008)

Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

Infusion reaction to infliximab biosimilar after transitioning from infliximab
por: Kashlan, Reem, et al.
Publicado: (2020)

A systematic review of infliximab in the treatment of early rheumatoid arthritis
por: Du Pan, Sophie Martin, et al.
Publicado: (2007)

The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients
por: Dwivedi, Ravi C, et al.
Publicado: (2009)

Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
por: Bobbio-Pallavicini, Francesca, et al.
Publicado: (2004)

Rheumatoid Arthritis: Refractory to Infliximab, a Tumor Necrosis Factor Inhibitor
por: Solehan, Hana Maizuliana bt, et al.
Publicado: (2011)

Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis
por: Mulleman, Denis, et al.
Publicado: (2009)

Serum ghrelin in female patients with rheumatoid arthritis during treatment with infliximab
por: Magiera, Michal, et al.
Publicado: (2011)

Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab
por: Dénarié, Delphine, et al.
Publicado: (2017)

Casual effect of methotrexate+etanercept/infliximab on survival of patients with rheumatoid arthritis
por: Akhlaghi, Saeed, et al.
Publicado: (2019)

The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses
por: Talotta, Rossella, et al.
Publicado: (2017)

Infliximab-Related Infusion Reactions: Systematic Review
por: Lichtenstein, Lev, et al.
Publicado: (2015)

Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis
por: Lequerré, Thierry, et al.
Publicado: (2006)

An Eight-Gene Blood Expression Profile Predicts the Response to Infliximab in Rheumatoid Arthritis
por: Julià, Antonio, et al.
Publicado: (2009)

Dynamics of longitudinal growth in children with idiopathic rheumatoid arthritis in response to infliximab treatment
por: Konopelko, OU, et al.
Publicado: (2011)

Intima-media thickness evolution after treatment with infliximab in patients with rheumatoid arthritis
por: Di Micco, Pierpaolo, et al.
Publicado: (2009)

74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis
por: Delabaye, Isabelle, et al.
Publicado: (2010)

Influence of Infliximab on Cytokines Network and Markers of Bone Remodeling in Rheumatoid Arthritis Patients
por: Korczowska, Izabela, et al.
Publicado: (2013)

Segmental vitiligo after infliximab use for rheumatoid arthritis - A case report
por: Carvalho, Clarissa Luiza Dalla Bernardina, et al.
Publicado: (2014)

Ramsay Hunt Syndrome in a Patient with Rheumatoid Arthritis after Treatment with Infliximab
por: Nagayama, Yoshio, et al.
Publicado: (2014)

Biologic-free remission by orthopaedic surgery in non-responder to infliximab for rheumatoid arthritis
por: Kanbe, Katsuaki, et al.
Publicado: (2015)

The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients
por: Bray, Vance J., et al.
Publicado: (2018)

Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy
por: Lu, Yun-Chi, et al.
Publicado: (2019)

Predictive Value of Serum Infliximab Levels at Induction Phase in Rheumatoid Arthritis Patients
por: Jurado, Teresa, et al.
Publicado: (2017)

Dendritic Nanotheranostic for the Delivery of Infliximab: A Potential Carrier in Rheumatoid Arthritis Therapy
por: Rodríguez-Prieto, Tamara, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept
por: Gholami, Ahmad, et al.
Publicado: (2021)

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
por: van der Maas, Aatke, et al.
Publicado: (2012)

Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease
por: Mesko, Bertalan, et al.
Publicado: (2013)

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab
por: Ellis, Lorie A, et al.
Publicado: (2019)

Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients
por: Lindberg, Johan, et al.
Publicado: (2006)

DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis
por: van Riel, Piet LCM, et al.
Publicado: (2005)

Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response
por: Marotte, H, et al.
Publicado: (2003)

Shared epitope and rheumatoid arthritis severity: association with infliximab treatment in a postmarketing study
por: Marotte, H, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_t6oijvle5blrnvnb6a10l9kgr7